Overview A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients Status: Completed Trial end date: 2012-11-01 Target enrollment: Participant gender: Summary To investigate the safety and efficacy of DE-101 to improve the signs and symptoms in dry-eye disease. Phase: Phase 2 Details Lead Sponsor: Santen Inc.